Trial Profile
Abuse potential of Samidorphan in healthy, nondependent, recreational opioid users
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Dec 2018
Price :
$35
*
At a glance
- Drugs Samidorphan (Primary)
- Indications Substance-related disorders
- Focus Pharmacodynamics
- 05 Dec 2018 New trial record
- 26 Nov 2018 Results published in the Journal of Clinical Pharmacology